1.
Isr Med Assoc J
; 17(7): 455-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26357726
Assuntos
Anemia Hemolítica Autoimune/tratamento farmacológico , Anticorpos Monoclonais Murinos/uso terapêutico , Ataxia Telangiectasia/tratamento farmacológico , Adolescente , Anemia Hemolítica Autoimune/imunologia , Ataxia Telangiectasia/imunologia , Crioglobulinas/imunologia , Humanos , Fatores Imunológicos/uso terapêutico , Masculino , Rituximab , Resultado do Tratamento
2.
Am J Hematol
; 76(3): 304-6, 2004 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15224375
RESUMO
We present a case of a 21-year-old woman suffering from diffuse large B-cell lymphoma who developed acute anterior uveitis shortly after completing chemotherapeutic course with HYPER-CVAD protocol (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) alternating with methotrexate and high-dose cytosine-arabinoside (HIDAC), with poor adherence to recommended prophylactic treatment with saline eye drops. Complete resolution of her symptoms was achieved within a few days of treatment with topical steroids. To our knowledge this is the first report of acute anterior uveitis secondary to treatment with HIDAC. Differential diagnosis and a suggested mechanism are discussed.